Orion Corporation: Managers’ transactions – Hilpi Rautelin

Core Insights - Orion Corporation has reported a transaction involving Hilpi Rautelin, a member of the Board, who received a share-based incentive on April 30, 2025 [1] - The transaction involved 508 shares with a unit price of 0 EUR, indicating a non-monetary incentive [1] Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a century of experience in developing, manufacturing, and marketing pharmaceuticals and active pharmaceutical ingredients [2] - The company focuses on oncology and pain management in its pharmaceutical R&D, with proprietary products aimed at treating cancer, neurological diseases, and respiratory diseases [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] - Orion's shares are listed on Nasdaq Helsinki, comprising both A and B shares [2]